Načítá se...
Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
Current hormonal therapies for prostate cancer are effective initially, but inevitably tumours progress to an advanced, metastatic stage, often referred to as ‘androgen independent’. However, the androgen receptor (AR) signalling pathway is still key for their growth. It is speculated that tumours e...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Society for Endocrinology
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2782800/ https://ncbi.nlm.nih.gov/pubmed/19635783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1677/ERC-09-0028 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|